-
1 Comment
D. Western Therapeutics Institute, Inc is currently in a long term downtrend where the price is trading 8.9% below its 200 day moving average.
From a valuation standpoint, the stock is 64.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 24.8.
D. Western Therapeutics Institute, Inc's total revenue sank by 10.6% to $115M since the same quarter in the previous year.
Its net income has dropped by 1044.3% to $-125M since the same quarter in the previous year.
Based on the above factors, D. Western Therapeutics Institute, Inc gets an overall score of 1/5.
| Exchange | TSE |
|---|---|
| CurrencyCode | JPY |
| ISIN | JP3548740004 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | 4B |
|---|---|
| PE Ratio | None |
| Target Price | None |
| Beta | -0.0 |
| Dividend Yield | None |
D. Western Therapeutics Institute, Inc., a biotechnology company, focuses on discovery and development of various drugs. The company offers GLANATEC and GLA-ALPHA, an ophthalmic solution for the treatment of glaucoma/ocular hypertension; DW-1001, an ophthalmic drug; DWR-2206, a regenerative medicine cell-product for bullous keratopathy; and DW-1002, an ophthalmic surgical adjuvant for cataract surgeries, and ILM, ALC, ERM, and PVR membrane staining. It is also developing DW-5LBT, a lidocaine patch for neuropathic pain after shingles; K-321 to treat fuch endothelial corneal dystrophy which is in Phase III clinical trials; and H-1337, a multi-kinase inhibitor that has started Phase IIb clinical trials for the treatment of glaucoma/ocular hypertension. The company was founded in 1999 and is headquartered in Nagoya, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 4576.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
